Guizhou Yibai Pharmaceutical Co Ltd (600594) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.013x

Based on the latest financial reports, Guizhou Yibai Pharmaceutical Co Ltd (600594) has a cash flow conversion efficiency ratio of 0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥33.28 Million ≈ $4.87 Million USD) by net assets (CN¥2.52 Billion ≈ $368.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check how strategically is Guizhou Yibai Pharmaceutical Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.

Guizhou Yibai Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Guizhou Yibai Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. See Guizhou Yibai Pharmaceutical Co Ltd book value and equity for net asset value and shareholders' equity analysis.

Guizhou Yibai Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guizhou Yibai Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sappi Ltd JSE:SAP	0.023x
Costamare Bulkers Holdings Limited NYSE:CMDB	0.034x
Shanghai Kehua Bio-Engineering Co Ltd SHE:002022	0.009x
Atrium Mortgage Investment Corp TO:AI	-0.048x
Burstone Group Limited JSE:BTN	0.014x
Guangdong Failong Crystal Technology Co Ltd SHE:300460	0.028x
NACL Industries Limited NSE:NACLIND	-0.131x
Beijing Succeeder Technology Inc SHG:688338	0.008x

Annual Cash Flow Conversion Efficiency for Guizhou Yibai Pharmaceutical Co Ltd (2002–2025)

The table below shows the annual cash flow conversion efficiency of Guizhou Yibai Pharmaceutical Co Ltd from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Guizhou Yibai Pharmaceutical Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.27 Billion ≈ $332.26 Million	CN¥256.71 Million ≈ $37.56 Million	0.113x	+239.16%
2024-12-31	CN¥2.61 Billion ≈ $381.36 Million	CN¥86.87 Million ≈ $12.71 Million	0.033x	-73.36%
2023-12-31	CN¥3.02 Billion ≈ $441.67 Million	CN¥377.61 Million ≈ $55.26 Million	0.125x	+15.58%
2022-12-31	CN¥3.19 Billion ≈ $466.79 Million	CN¥345.30 Million ≈ $50.53 Million	0.108x	-58.72%
2021-12-31	CN¥3.56 Billion ≈ $521.30 Million	CN¥934.21 Million ≈ $136.70 Million	0.262x	+147.69%
2020-12-31	CN¥3.46 Billion ≈ $506.76 Million	CN¥366.66 Million ≈ $53.65 Million	0.106x	+8.67%
2019-12-31	CN¥3.72 Billion ≈ $544.80 Million	CN¥362.71 Million ≈ $53.08 Million	0.097x	+77.78%
2018-12-31	CN¥3.91 Billion ≈ $572.24 Million	CN¥214.30 Million ≈ $31.36 Million	0.055x	-62.69%
2017-12-31	CN¥4.64 Billion ≈ $679.20 Million	CN¥681.78 Million ≈ $99.77 Million	0.147x	+61.80%
2016-12-31	CN¥4.19 Billion ≈ $613.53 Million	CN¥380.62 Million ≈ $55.70 Million	0.091x	-43.82%
2015-12-31	CN¥3.55 Billion ≈ $519.48 Million	CN¥573.68 Million ≈ $83.95 Million	0.162x	+2.18%
2014-12-31	CN¥3.42 Billion ≈ $501.09 Million	CN¥541.58 Million ≈ $79.25 Million	0.158x	-47.05%
2013-12-31	CN¥1.93 Billion ≈ $282.78 Million	CN¥577.24 Million ≈ $84.47 Million	0.299x	+60.29%
2012-12-31	CN¥1.55 Billion ≈ $226.16 Million	CN¥288.01 Million ≈ $42.15 Million	0.186x	-23.66%
2011-12-31	CN¥1.14 Billion ≈ $166.55 Million	CN¥277.83 Million ≈ $40.65 Million	0.244x	+84.89%
2010-12-31	CN¥876.05 Million ≈ $128.19 Million	CN¥115.66 Million ≈ $16.92 Million	0.132x	-9.65%
2009-12-31	CN¥710.95 Million ≈ $104.03 Million	CN¥103.88 Million ≈ $15.20 Million	0.146x	-53.82%
2008-12-31	CN¥598.16 Million ≈ $87.53 Million	CN¥189.26 Million ≈ $27.69 Million	0.316x	+1304.16%
2007-12-31	CN¥530.04 Million ≈ $77.56 Million	CN¥11.94 Million ≈ $1.75 Million	0.023x	-89.98%
2006-12-31	CN¥425.69 Million ≈ $62.29 Million	CN¥95.77 Million ≈ $14.01 Million	0.225x	+608.46%
2005-12-31	CN¥547.39 Million ≈ $80.10 Million	CN¥17.38 Million ≈ $2.54 Million	0.032x	+135.92%
2004-12-31	CN¥506.70 Million ≈ $74.15 Million	CN¥-44.80 Million ≈ $-6.56 Million	-0.088x	-117.30%
2003-12-31	CN¥180.22 Million ≈ $26.37 Million	CN¥92.10 Million ≈ $13.48 Million	0.511x	-10.81%
2002-12-31	CN¥128.20 Million ≈ $18.76 Million	CN¥73.46 Million ≈ $10.75 Million	0.573x	--

About Guizhou Yibai Pharmaceutical Co Ltd

SHG:600594 China Drug Manufacturers - Specialty & Generic

Market Cap

$409.07 Million

CN¥2.80 Billion CNY

Market Cap Rank

#13553 Global

#4147 in China

Share Price

CN¥3.53

Change (1 day)

-1.40%

52-Week Range

CN¥3.45 - CN¥5.06

All Time High

CN¥19.64